(MANH) Manhattan Associates - Overview
Exchange: NASDAQ •
Country: United States •
Currency: USD •
Type: Common Stock •
ISIN: US5627501092
Stock: Supply Chain, Warehouse, Transportation, Order Management
Total Rating 53
Risk 95
Buy Signal -0.10
| Risk 5d forecast | |
|---|---|
| Volatility | 38.6% |
| Relative Tail Risk | -11.5% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | -0.27 |
| Alpha | -37.10 |
| Character TTM | |
|---|---|
| Beta | 1.106 |
| Beta Downside | -0.095 |
| Drawdowns 3y | |
|---|---|
| Max DD | 58.00% |
| CAGR/Max DD | -0.01 |
EPS (Earnings per Share)
Revenue
Description: MANH Manhattan Associates February 26, 2026
Manhattan Associates (NASDAQ: MANH) delivers end-to-end supply-chain software, including cloud-native warehouse management (Manhattan Active WMS), transportation management, omni-channel order fulfillment (Manhattan Active Omni), and unified business planning tools, supplemented by professional services, hardware resale, and maintenance for on-premise customers.
In its most recent fiscal year (FY 2025), MANH reported revenue of $2.38 billion, a 12% year-over-year increase, driven largely by a 31% rise in subscription-based cloud ARR and an operating margin expansion to 18.5%, reflecting strong adoption of its version-less platform.
Key macro and sector drivers include sustained e-commerce growth (global online sales projected to exceed $8 trillion in 2026), ongoing labor shortages in warehousing that push firms toward automation, and volatile freight costs that heighten demand for sophisticated transportation management solutions.
For deeper insights, you might explore ValueRay’s analyst coverage of MANH.
Headlines to watch out for
- Cloud-native software adoption drives subscription revenue growth
- Supply chain disruptions increase demand for optimization software
- Professional services demand fluctuates with software implementation cycles
- Competition from larger enterprise software vendors impacts market share
Piotroski VR‑10 (Strict, 0-10) 7.5
| Net Income: 219.9m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.45 > 0.02 and ΔFCF/TA 6.76 > 1.0 |
| NWC/Revenue: 11.78% < 20% (prev 9.88%; Δ 1.91% < -1%) |
| CFO/TA 0.46 > 3% & CFO 389.5m > Net Income 219.9m |
| Net Debt (-216.4m) to EBITDA (293.8m): -0.74 < 3 |
| Current Ratio: 1.28 > 1.5 & < 3 |
| Outstanding Shares: last quarter (60.6m) vs 12m ago -2.20% < -2% |
| Gross Margin: 55.88% > 18% (prev 0.54%; Δ 5.53k% > 0.5%) |
| Asset Turnover: 135.4% > 50% (prev 137.6%; Δ -2.16% > 0%) |
| Interest Coverage Ratio: 180.6 > 6 (EBITDA TTM 293.8m / Interest Expense TTM 1.59m) |
Altman Z'' 5.39
| A: 0.15 (Total Current Assets 583.3m - Total Current Liabilities 455.9m) / Total Assets 839.4m |
| B: 0.41 (Retained Earnings 345.1m / Total Assets 839.4m) |
| C: 0.36 (EBIT TTM 287.5m / Avg Total Assets 798.5m) |
| D: 0.60 (Book Value of Equity 314.8m / Total Liabilities 524.6m) |
| Altman-Z'' Score: 5.39 = AAA |
Beneish M -3.33
| DSRI: 0.98 (Receivables 214.7m/210.7m, Revenue 1.08b/1.04b) |
| GMI: 0.97 (GM 55.88% / 54.21%) |
| AQI: 0.86 (AQ_t 0.22 / AQ_t-1 0.25) |
| SGI: 1.04 (Revenue 1.08b / 1.04b) |
| TATA: -0.20 (NI 219.9m - CFO 389.5m) / TA 839.4m) |
| Beneish M-Score: -3.33 (Cap -4..+1) = AA |
What is the price of MANH shares?
As of March 16, 2026, the stock is trading at USD 140.78 with a total of 676,998 shares traded.
Over the past week, the price has changed by -6.25%, over one month by -0.60%, over three months by -17.17% and over the past year by -19.85%.
Over the past week, the price has changed by -6.25%, over one month by -0.60%, over three months by -17.17% and over the past year by -19.85%.
Is MANH a buy, sell or hold?
Manhattan Associates has received a consensus analysts rating of 4.20.
Therefore, it is recommended to buy MANH.
- StrongBuy: 5
- Buy: 2
- Hold: 3
- Sell: 0
- StrongSell: 0
What are the forecasts/targets for the MANH price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 208.6 | 48.2% |
| Analysts Target Price | 208.6 | 48.2% |
MANH Fundamental Data Overview March 15, 2026
P/E Trailing = 39.1056
P/E Forward = 26.8817
P/S = 7.8447
P/B = 26.672
P/EG = 1.8036
Revenue TTM = 1.08b USD
EBIT TTM = 287.5m USD
EBITDA TTM = 293.8m USD
Long Term Debt = 56.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = unknown (none)
Debt = 112.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -216.4m USD (from netDebt column, last quarter)
Enterprise Value = 8.27b USD (8.48b + Debt 112.4m - CCE 328.7m)
Interest Coverage Ratio = 180.6 (Ebit TTM 287.5m / Interest Expense TTM 1.59m)
EV/FCF = 22.10x (Enterprise Value 8.27b / FCF TTM 374.0m)
FCF Yield = 4.52% (FCF TTM 374.0m / Enterprise Value 8.27b)
FCF Margin = 34.59% (FCF TTM 374.0m / Revenue TTM 1.08b)
Net Margin = 20.34% (Net Income TTM 219.9m / Revenue TTM 1.08b)
Gross Margin = 55.88% ((Revenue TTM 1.08b - Cost of Revenue TTM 477.1m) / Revenue TTM)
Gross Margin QoQ = 54.41% (prev 55.96%)
Tobins Q-Ratio = 9.85 (Enterprise Value 8.27b / Total Assets 839.4m)
Interest Expense / Debt = 0.59% (Interest Expense 667k / Debt 112.4m)
Taxrate = 24.10% (16.5m / 68.5m)
NOPAT = 218.2m (EBIT 287.5m * (1 - 24.10%))
Current Ratio = 1.28 (Total Current Assets 583.3m / Total Current Liabilities 455.9m)
Debt / Equity = 0.36 (Debt 112.4m / totalStockholderEquity, last quarter 314.8m)
Debt / EBITDA = -0.74 (Net Debt -216.4m / EBITDA 293.8m)
Debt / FCF = -0.58 (Net Debt -216.4m / FCF TTM 374.0m)
Total Stockholder Equity = 287.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 27.55% (Net Income 219.9m / Total Assets 839.4m)
RoE = 76.65% (Net Income TTM 219.9m / Total Stockholder Equity 287.0m)
RoCE = 83.78% (EBIT 287.5m / Capital Employed (Equity 287.0m + L.T.Debt 56.2m))
RoIC = 76.04% (NOPAT 218.2m / Invested Capital 287.0m)
WACC = 9.87% (E(8.48b)/V(8.60b) * Re(9.99%) + D(112.4m)/V(8.60b) * Rd(0.59%) * (1-Tc(0.24)))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.54%
[DCF] Terminal Value 75.45% ; FCFF base≈338.9m ; Y1≈418.1m ; Y5≈712.1m
[DCF] Fair Price = 149.2 (EV 8.71b - Net Debt -216.4m = Equity 8.93b / Shares 59.8m; r=9.87% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 93.49 | EPS CAGR: 20.57% | SUE: 1.46 | # QB: 16
Revenue Correlation: 94.05 | Revenue CAGR: 11.63% | SUE: 1.43 | # QB: 4
EPS next Quarter (2026-06-30): EPS=1.31 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-7 | Analysts=11
EPS current Year (2026-12-31): EPS=5.22 | Chg7d=+0.000 | Chg30d=-0.003 | Revisions Net=-8 | Growth EPS=+3.1% | Growth Revenue=+6.0%
EPS next Year (2027-12-31): EPS=5.84 | Chg7d=+0.000 | Chg30d=-0.019 | Revisions Net=-3 | Growth EPS=+11.9% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: -0.78 (1 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.4% (Discount Rate 10.0% - Earnings Yield 2.6%)
[Growth] Growth Spread = -1.6% (Analyst 5.8% - Implied 7.4%)
P/E Forward = 26.8817
P/S = 7.8447
P/B = 26.672
P/EG = 1.8036
Revenue TTM = 1.08b USD
EBIT TTM = 287.5m USD
EBITDA TTM = 293.8m USD
Long Term Debt = 56.2m USD (from capitalLeaseObligations, last quarter)
Short Term Debt = unknown (none)
Debt = 112.4m USD (from shortLongTermDebtTotal, last quarter)
Net Debt = -216.4m USD (from netDebt column, last quarter)
Enterprise Value = 8.27b USD (8.48b + Debt 112.4m - CCE 328.7m)
Interest Coverage Ratio = 180.6 (Ebit TTM 287.5m / Interest Expense TTM 1.59m)
EV/FCF = 22.10x (Enterprise Value 8.27b / FCF TTM 374.0m)
FCF Yield = 4.52% (FCF TTM 374.0m / Enterprise Value 8.27b)
FCF Margin = 34.59% (FCF TTM 374.0m / Revenue TTM 1.08b)
Net Margin = 20.34% (Net Income TTM 219.9m / Revenue TTM 1.08b)
Gross Margin = 55.88% ((Revenue TTM 1.08b - Cost of Revenue TTM 477.1m) / Revenue TTM)
Gross Margin QoQ = 54.41% (prev 55.96%)
Tobins Q-Ratio = 9.85 (Enterprise Value 8.27b / Total Assets 839.4m)
Interest Expense / Debt = 0.59% (Interest Expense 667k / Debt 112.4m)
Taxrate = 24.10% (16.5m / 68.5m)
NOPAT = 218.2m (EBIT 287.5m * (1 - 24.10%))
Current Ratio = 1.28 (Total Current Assets 583.3m / Total Current Liabilities 455.9m)
Debt / Equity = 0.36 (Debt 112.4m / totalStockholderEquity, last quarter 314.8m)
Debt / EBITDA = -0.74 (Net Debt -216.4m / EBITDA 293.8m)
Debt / FCF = -0.58 (Net Debt -216.4m / FCF TTM 374.0m)
Total Stockholder Equity = 287.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 27.55% (Net Income 219.9m / Total Assets 839.4m)
RoE = 76.65% (Net Income TTM 219.9m / Total Stockholder Equity 287.0m)
RoCE = 83.78% (EBIT 287.5m / Capital Employed (Equity 287.0m + L.T.Debt 56.2m))
RoIC = 76.04% (NOPAT 218.2m / Invested Capital 287.0m)
WACC = 9.87% (E(8.48b)/V(8.60b) * Re(9.99%) + D(112.4m)/V(8.60b) * Rd(0.59%) * (1-Tc(0.24)))
Discount Rate = 9.99% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: -100.0 | Cagr: -1.54%
[DCF] Terminal Value 75.45% ; FCFF base≈338.9m ; Y1≈418.1m ; Y5≈712.1m
[DCF] Fair Price = 149.2 (EV 8.71b - Net Debt -216.4m = Equity 8.93b / Shares 59.8m; r=9.87% [WACC]; 5y FCF grow 25.0% → 2.90% )
EPS Correlation: 93.49 | EPS CAGR: 20.57% | SUE: 1.46 | # QB: 16
Revenue Correlation: 94.05 | Revenue CAGR: 11.63% | SUE: 1.43 | # QB: 4
EPS next Quarter (2026-06-30): EPS=1.31 | Chg7d=+0.000 | Chg30d=+0.000 | Revisions Net=-7 | Analysts=11
EPS current Year (2026-12-31): EPS=5.22 | Chg7d=+0.000 | Chg30d=-0.003 | Revisions Net=-8 | Growth EPS=+3.1% | Growth Revenue=+6.0%
EPS next Year (2027-12-31): EPS=5.84 | Chg7d=+0.000 | Chg30d=-0.019 | Revisions Net=-3 | Growth EPS=+11.9% | Growth Revenue=+8.8%
[Analyst] Revisions Ratio: -0.78 (1 Up / 8 Down within 30d for Next Quarter)
[Growth] Implied Growth Rate = 7.4% (Discount Rate 10.0% - Earnings Yield 2.6%)
[Growth] Growth Spread = -1.6% (Analyst 5.8% - Implied 7.4%)